Literature DB >> 6619234

Hawkinsinuria--identification of quinolacetic acid and pyroglutamic acid during an acidotic phase.

C H Hocart, B Halpern, L A Hick, C O Wong.   

Abstract

A second Australian family with the genetic disease Hawkinsinuria has been identified. Affected members excrete hawkinsin and cis- and trans-4-hydroxycyclohexylacetic acid. An infant in this family presented with metabolic acidosis and excreted quinolacetic acid and pyroglutamic acid in the urine together with the tyrosine derived phenolic acids reported in the original index case. It is thought that quinolacetic acid is accumulated as a by-product of the partially defective enzyme, 4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) and that pyroglutamic acid indicated lowered glutathione levels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619234     DOI: 10.1016/s0378-4347(00)84371-6

Source DB:  PubMed          Journal:  J Chromatogr


  2 in total

1.  Expanding the phenotype of hawkinsinuria: new insights from response to N-acetyl-L-cysteine.

Authors:  Natalia Gomez-Ospina; Anna I Scott; Gia J Oh; Donald Potter; Veena V Goel; Lauren Destino; Nancy Baugh; Gregory M Enns; Anna-Kaisa Niemi; Tina M Cowan
Journal:  J Inherit Metab Dis       Date:  2016-08-03       Impact factor: 4.982

2.  Prenatal analysis in two suspected cases of glutathione synthetase deficiency.

Authors:  E Erasmus; L J Mienie; W N de Vries; W J de Wet; B Carlsson; A Larsson
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.